Target 2035 - an update on private sector contributions
This journal is © The Royal Society of Chemistry..
Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging 'open' principles to develop a pharmacological tool for every human protein. These tools are important reagents for scientists studying human health and disease and will facilitate the development of new medicines. It is therefore not surprising that pharmaceutical companies are joining Target 2035, contributing both knowledge and reagents to study novel proteins. Here, we present a brief progress update on Target 2035 and highlight some of industry's contributions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
RSC medicinal chemistry - 14(2023), 6 vom: 22. Juni, Seite 1002-1011 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 01.07.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1039/d2md00441k |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358617561 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358617561 | ||
| 003 | DE-627 | ||
| 005 | 20231226075130.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1039/d2md00441k |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1195.xml |
| 035 | |a (DE-627)NLM358617561 | ||
| 035 | |a (NLM)37360399 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ackloo, Suzanne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Target 2035 - an update on private sector contributions |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.07.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a This journal is © The Royal Society of Chemistry. | ||
| 520 | |a Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging 'open' principles to develop a pharmacological tool for every human protein. These tools are important reagents for scientists studying human health and disease and will facilitate the development of new medicines. It is therefore not surprising that pharmaceutical companies are joining Target 2035, contributing both knowledge and reagents to study novel proteins. Here, we present a brief progress update on Target 2035 and highlight some of industry's contributions | ||
| 650 | 4 | |a Editorial | |
| 700 | 1 | |a Antolin, Albert A |e verfasserin |4 aut | |
| 700 | 1 | |a Bartolome, Jose Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Beck, Hartmut |e verfasserin |4 aut | |
| 700 | 1 | |a Bullock, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Betz, Ulrich A K |e verfasserin |4 aut | |
| 700 | 1 | |a Böttcher, Jark |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Chaturvedi, Menorca |e verfasserin |4 aut | |
| 700 | 1 | |a Crisp, Alisa |e verfasserin |4 aut | |
| 700 | 1 | |a Daniels, Danette |e verfasserin |4 aut | |
| 700 | 1 | |a Dreher, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Edfeldt, Kristina |e verfasserin |4 aut | |
| 700 | 1 | |a Edwards, Aled M |e verfasserin |4 aut | |
| 700 | 1 | |a Egner, Ursula |e verfasserin |4 aut | |
| 700 | 1 | |a Elkins, Jon |e verfasserin |4 aut | |
| 700 | 1 | |a Fischer, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Glendorf, Tine |e verfasserin |4 aut | |
| 700 | 1 | |a Goldberg, Steven |e verfasserin |4 aut | |
| 700 | 1 | |a Hartung, Ingo V |e verfasserin |4 aut | |
| 700 | 1 | |a Hillisch, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Homan, Evert |e verfasserin |4 aut | |
| 700 | 1 | |a Knapp, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Köster, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Krämer, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Llaveria, Josep |e verfasserin |4 aut | |
| 700 | 1 | |a Lessel, Uta |e verfasserin |4 aut | |
| 700 | 1 | |a Lindemann, Sven |e verfasserin |4 aut | |
| 700 | 1 | |a Linderoth, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Matsui, Hisanori |e verfasserin |4 aut | |
| 700 | 1 | |a Michel, Maurice |e verfasserin |4 aut | |
| 700 | 1 | |a Montel, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Mueller-Fahrnow, Anke |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Susanne |e verfasserin |4 aut | |
| 700 | 1 | |a Owen, Dafydd R |e verfasserin |4 aut | |
| 700 | 1 | |a Saikatendu, Kumar Singh |e verfasserin |4 aut | |
| 700 | 1 | |a Santhakumar, Vijayaratnam |e verfasserin |4 aut | |
| 700 | 1 | |a Sanderson, Wendy |e verfasserin |4 aut | |
| 700 | 1 | |a Scholten, Cora |e verfasserin |4 aut | |
| 700 | 1 | |a Schapira, Matthieu |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Sujata |e verfasserin |4 aut | |
| 700 | 1 | |a Shireman, Brock |e verfasserin |4 aut | |
| 700 | 1 | |a Sundström, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Todd, Matthew H |e verfasserin |4 aut | |
| 700 | 1 | |a Tredup, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Venable, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Willson, Timothy M |e verfasserin |4 aut | |
| 700 | 1 | |a Arrowsmith, Cheryl H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t RSC medicinal chemistry |d 2020 |g 14(2023), 6 vom: 22. Juni, Seite 1002-1011 |w (DE-627)NLM320418669 |x 2632-8682 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g number:6 |g day:22 |g month:06 |g pages:1002-1011 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1039/d2md00441k |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |e 6 |b 22 |c 06 |h 1002-1011 | ||